Page last updated: 2024-10-20

uric acid and Thymoma

uric acid has been researched along with Thymoma in 2 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Thymoma: A neoplasm originating from thymic tissue, usually benign, and frequently encapsulated. Although it is occasionally invasive, metastases are extremely rare. It consists of any type of thymic epithelial cell as well as lymphocytes that are usually abundant. Malignant lymphomas that involve the thymus, e.g., lymphosarcoma, Hodgkin's disease (previously termed granulomatous thymoma), should not be regarded as thymoma. (From Stedman, 25th ed)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yang, D1
Su, Z1
Wu, S1
Bi, Y1
Li, X1
Li, J1
Lou, K1
Zhang, H1
Zhang, X1
Hu, DE1
Moore, AM1
Thomsen, LL1
Brindle, KM1

Other Studies

2 other studies available for uric acid and Thymoma

ArticleYear
Low antioxidant status of serum bilirubin, uric acid, albumin and creatinine in patients with myasthenia gravis.
    The International journal of neuroscience, 2016, Volume: 126, Issue:12

    Topics: Adult; Aged; Bilirubin; Creatinine; Female; Humans; Male; Middle Aged; Myasthenia Gravis; Oxidative

2016
Uric acid promotes tumor immune rejection.
    Cancer research, 2004, Aug-01, Volume: 64, Issue:15

    Topics: Allopurinol; Animals; Apoptosis; Cell Division; Chickens; Enzyme Inhibitors; Female; Graft Rejection

2004